# Benchmarking Management of Glaucoma Using the Diopsys VEP/PERG Protocols.

> **NCT02594280** · — · UNKNOWN · sponsor: **Diopsys, Inc.** · enrollment: 60 (estimated)

## Conditions studied

- Glaucoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02594280
- **Lead sponsor:** Diopsys, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-02-15
- **Primary completion:** 2018-12-15
- **Final completion:** 2019-05-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2018-01-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02594280

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02594280, "Benchmarking Management of Glaucoma Using the Diopsys VEP/PERG Protocols.". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT02594280. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*